Title:
CRYSTALLINE FORMS OF 5-FLUORO-1-(4-FLUORO-3-(4-(PYRIMIDIN-2-YL)PIPERAZINE-1-CARBONYL)BENZYL)QUINAZOLINE-2,4(1H,3H)-DIONE AND PREPARATION THEREFOR
Document Type and Number:
WIPO Patent Application WO/2022/099442
Kind Code:
A1
Abstract:
The present invention relates to crystalline forms of 5-fluoro-1-(4-fluoro-3-(4-(pyrimidin-2-yl)piperazine-1-carbonyl)benzyl)quinazoline-2,4(1H,3H)-dione selected from crystalline forms VIII, I, II, III, V, VI and the like.
Inventors:
CAI SUI XIONG (CN)
MA NING (CN)
YANG YISHENG (CN)
YANG KAI (CN)
MA NING (CN)
YANG YISHENG (CN)
YANG KAI (CN)
Application Number:
PCT/CN2020/127733
Publication Date:
May 19, 2022
Filing Date:
November 10, 2020
Export Citation:
Assignee:
IMPACT THERAPEUTICS SHANGHAI INC (CN)
International Classes:
C07D239/96; A61P9/00; A61P35/00
Domestic Patent References:
| WO2017167251A1 | 2017-10-05 | |||
| WO2012130166A1 | 2012-10-04 | |||
| WO2012125521A1 | 2012-09-20 | |||
| WO2016155655A1 | 2016-10-06 | |||
| WO2013064083A1 | 2013-05-10 |
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (CN)
Download PDF: